Background

Brendan completed a Bachelor of Health Science (Honours) in 2016 through Burnet Institute and Monash University with a project based on STI and HIV risk among men who have sex with men.

Currently Brendan is a research assistant with Burnet Institute and Alfred Hospital Department of Infectious Diseases working on a range of hepatitis C related studies among men who have sex with men and people who inject drugs. He is also completing a Master of Public Health with Monash University.

Positions

• 2018- ongoing: Research Assistant, Burnet Institute
• 2017-ongoing: Data Analyst and Research Assistant, The Alfred/Monash University Department of Infectious Diseases

Qualifications

• 2016: Bachelor of Health Science (Honours) Monash University, Australia
• 2015: Bachelor of Science (Biotechnology)/Bachelor of Commerce (Commercial Law) Swinburne University, Australia

Awards

• 2018: Academic Scholarship, International Symposium on Hepatitis Care in Substance Users, Portugal
• 2017: Sexual Health Society of Victoria Education Grant, STI & HIV World Congress, Brazil

Projects (3)

Current (2)

• 

  co-EC Study: Eliminating hepatitis C/HIV coinfection

• 

  The elimination of hepatitis C as a global public health threat

Publications (7)

2021 (5)

• Routine testing for syphilis and other bacterial sexually transmissible infections is required among people in prison.
  Harney B, Doyle J, Hellard M, Stoové M, Winter R
  Sex Transm Dis. 2021 Aug; 48(10):e153
• Patient-reported outcomes of the Treatment and Prevention Study: A real-world community-based trial of direct-acting antivirals for hepatitis C among people who inject drugs.
  Goutzamanis S, Spelman T, Harney B, Dietze P, Stoové M, Higgs P, Thompson A, Doyle JS, Hellard M; Treatment, Prevention Study group.
  J Viral Hepat. 2021 Apr; 28(7):1068-1077
• Hepatitis C treatment in a co-located mental health and alcohol and drug service using a nurse-led model of care.
  Harney BL, Brereton R, Whitton B, Pietrzak D, Paige E, Roberts SK, Birks S, Saraf S, Hellard ME, Doyle JS
  J Viral Hepat. 2021 Feb; 28(5):771-778
• Micro-elimination of hepatitis C among people with HIV coinfection: declining incidence and prevalence accompanying a multi-center treatment scale-up trial.
  Doyle JS, van Santen DK, Iser D, Sasadeusz J, O'Reilly M, Harney B, Traeger MW, Roney J, Cutts JC, Bowring AL, Winter R, Medland N, Fairley CK, Moore R, Tee B, Asselin J, El-Hayek C, Hoy JF, Matthews GV, Prins M, Stoové MA, Hellard ME
  Clin Infect Dis. 2021 Jan; Epub ahead of print
• Letter to the Editor: Recommendations for implementing hepatitis C virus care in homeless shelters: The stakeholder perspective.
  Harney B, McColl R, Pedrana A, Morrison E, Doyle J, Hellard M, Higgs P
  Hepatol Commun. 2021 Jan; 5(1):146-147

2019 (2)

• Quantitative evaluation of an integrated nurse model of care providing hepatitis C treatment to people attending homeless services in Melbourne, Australia.
  Harney BL, Whitton B, Lim C, Paige E, McDonald B, Nolan S, Pemberton D, Hellard ME, Doyle JS
  Int J Drug Policy. 2019 Oct; 72:195-198
• Risk of Subsequent HIV Infection Following Sexually Transmissible Infections Among Men Who Have Sex With Men.
  Harney BL, Agius PA, El-Hayek C, Fairley CK, Chow EPF, Roth N, Tee BK, Leslie D, Tachedjian G, Hellard M, Stoové M
  Open Forum Infect Dis. 2019 Oct; 6(10):ofz376

News Articles (2)

2021 (1)

• IAS award for Burnet researcher

2019 (1)

• NHMRC Ideas Grants